Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
|Articles|February 1, 2003
- Volume 0 0
Antidepressant Use During Pregnancy Does Not Affect Child Development
Advertisement
Use of antidepressants during pregnancy does not affect child development, according to a prospective study published in the American Journal of Psychiatry.
Researchers compared mother?child pairs who were exposed to tricyclic antidepres-sants (n = 46) or fluoxetine (n = 40) during gestation with an unexposed, nonde-pressed control group (n = 36). Neither tricyclic antidepressants nor fluoxetine affected the child?s global IQ, language development, or behavior.
Instead, the mothers? depression was associated with impaired cognitive and language achievement among their children.
Articles in this issue
over 23 years ago
Calcium and Vitamin D Prevent Tooth Lossover 23 years ago
Soy May Not Increase Bone Mineral Density in Young Womenover 23 years ago
Hormone Therapy, Antioxidants Do Not Protect Against Heart Diseaseover 23 years ago
All Pregnant Women Should Be Screened for Group B Strepover 23 years ago
Cervical Cancer Screening Not Urged for Allover 23 years ago
Bacterial Vaginosis Linked to Miscarriagesover 23 years ago
Dietary Factors Linked to High Iron Storesover 23 years ago
Growth Hormone Linked to Adverse Effectsover 23 years ago
Topical b-Blockers May Affect Airways Function in Elderly PatientsAdvertisement
Related to this article
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bridging the Gap: Pharmacist Experiences Obtaining DEA Licenses
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Expert Q&A: Pharmacists Address Pneumococcal Vaccine Hesitancy and Screening Complexity in Transitions of Care
4
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
5